Press Releases

All Releases
View Summary Arbutus Announces Appointment of Daniel Burgess to Board of Directors
Mar 23, 2017
PDF 8.9 KB Add to Briefcase
View Summary Arbutus Announces Year-End 2016 Financial Results
Mar 21, 2017
PDF 29.5 KB Add to Briefcase
View Summary Arbutus Licenses LNP Delivery Technology to Alexion for Use in Single Messenger RNA Product Candidate
Mar 16, 2017
PDF 12.3 KB Add to Briefcase
View Summary Arbutus to Participate in Upcoming Investor Conferences
Mar 6, 2017
PDF 10.0 KB Add to Briefcase
View Summary Arbutus to Participate in Upcoming Investor Conferences
Feb 9, 2017
PDF 10.8 KB Add to Briefcase
View Summary Arbutus Is Granted a Pre-trial Injunction Restraining Acuitas From Entering Into Agreements Sublicensing Arbutus LNP Technology
Feb 8, 2017
PDF 12.5 KB Add to Briefcase
View Summary Arbutus Provides Additional Data from the ARB-1467 Phase II Clinical Trial in HBV Patients
Dec 12, 2016
PDF 18.5 KB Add to Briefcase
View Summary Arbutus Presents HBV Drug Combination Studies at AASLD
Nov 14, 2016
PDF 14.1 KB Add to Briefcase
View Summary Arbutus Provides Corporate Update and Announces Third Quarter 2016 Financial Results
Nov 3, 2016
PDF 29.5 KB Add to Briefcase
View Summary Arbutus Recognizes Liver Cancer Awareness Month with Grant to Support the Hepatitis B Foundation's Patient Storytelling Campaign
Oct 3, 2016
PDF 9.8 KB Add to Briefcase
View Summary Arbutus to Present HBV Data at the 2016 AASLD Liver Meeting
Oct 1, 2016
PDF 15.7 KB Add to Briefcase
View Summary Arbutus Reports Interim Multi-Dose Results from Phase II Clinical Trial of ARB-1467 in Patients with Chronic HBV Infection
Sep 29, 2016
PDF 17.2 KB Add to Briefcase
View Summary Arbutus' Chief Scientific Officer, Dr. Michael J. Sofia, Awarded the 2016 Lasker~DeBakey Clinical Medical Research Award
Sep 13, 2016
PDF 9.8 KB Add to Briefcase
View Summary Arbutus to Present at the 2016 Wedbush PacGrow Healthcare Conference
Aug 10, 2016
PDF 8.0 KB Add to Briefcase
View Summary Arbutus Announces Issuance of Broad New US Patent for LNP Delivery Technology
Aug 8, 2016
PDF 12.5 KB Add to Briefcase
View Summary Arbutus Provides Corporate Update and Announces Second Quarter 2016 Financial Results
Aug 4, 2016
PDF 29.9 KB Add to Briefcase
View Summary Arbutus Reports Topline Results from TKM-PLK1 HCC Clinical Trial
Jul 19, 2016
PDF 15.3 KB Add to Briefcase
View Summary Arbutus to Present Data on New LNP Formulations for Delivery of mRNA at the 2016 Controlled Release Society Conference
Jul 18, 2016
PDF 11.9 KB Add to Briefcase
View Summary Arbutus to Present mRNA Delivery Data at the 32nd Annual Meeting of the Japan Society of Drug Delivery System
Jun 30, 2016
PDF 12.2 KB Add to Briefcase
View Summary Arbutus to Participate in Upcoming Investor Conferences
Jun 3, 2016
PDF 10.6 KB Add to Briefcase
Showing 1-20 of 321 Page: 1 2 3 4 5 ... 17  Next 20
Add to Briefcase = add release to Briefcase